 Manchester Bio-Community
Manchester is at the epicentre of biotechnology development and fast becoming the UK´s biggest and best biotech base.
Manchester Bio-community is the optimal environment for success in biotechnology and comprises:
o Four universities that provide world-leading teaching and research.
o Five university teaching hospitals and their associated clinical research centres.
o Numerous centres of excellence and intra-city and cross-regional bio-science networks and initiatives.
o Sector-specific experienced professional services, technology transfer and business support services
Biotech companies: Manchester is the ideal environment for the successful growth of biotech companies at all stages of development.
Biomedical establishments: Manchesters biomedical sector includes several centres of excellence and provides access to world leading expertise, from research through to the clinic.
Specialist Enabling services & Facilities: Manchester Bio-community provides accommodation, innovation and business support services, and effective networks. An entrepreneurial culture encourages collaboration and facilitates the development and growth of bio-science commercial opportunities.
As a key member of the Northwest biotech cluster, Manchester bio-community is strongly supported by the Northwest Development Agency’s sector group, Bionow.
To download the Manchester Bio-community map click here.
The Manchester Biotech Benefits
Tenants in UMICs Biotech facilities can benefit from:
A relationship with The University of Manchester the largest single site university in the UK
– Collaborative opportunities (commercial or research-based)
– Introduction to The Universitys investment funds (Proof of Concept, Follow on Fund, Manchester Technology Fund)
– Access to modern hi-specification biotechnology incubation laboratories
– Links to any relevant initiatives such as the GMP Clean Room Unit (UK Centre for Tissue Regeneration/NW Embryonic Stem Cell Centre, the Manchester Cancer Centre; the Wellcome Trust Clinical Research Facility; and the NW Genetics Knowledge Park
– Access to the Manchester Momentum consortium of SMEs and companies that are associated with the University
– Access to Manchester Business School (ranked 22 in the world) and its virtual business incubator
Links to relevant & high profile clinical activities
– Facilitation of relationships with major, R&D active, NHS Trusts in Manchester
– Facilitated access to relevant regional clinical units
– Access to NW regional patient base of 7 million (>3million in Greater Manchester region)
– Facilitated introduction to local ethics committee for clinical/translation projects
– New £40m Biomedical Research Centre (BMRC) Manchester is in line for one of these 5 clinical centres in the UK, which will be the premier sites for clinical research in the UK
Strong city and regional development support and connectivity
– Support for businesses relocating to the NW through the NW Regional Development Agency, BIONOW and/or MIDAS
– Business support and access to strong and diverse business associate network
– Convenient access to Manchester Airport – the UKs third largest airport which currently handles 20 million passengers a year, offering direct flights to over 180 destinations worldwide by over 90 airlines
– Rail network rapid links to the whole of the UK (only 2h15 to London)
|
